Skip to main content

and
  1. No Access

    Article

    A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targeting

    Here, we describe a method of systematic PCR screening with multiround sample pooling for the isolation of rare PCR-positive samples. As an example, we have applied this protocol to the recovery of gene-target...

    Hiroyuki Konishi, Josh Lauring, Joseph P Garay, Bedri Karakas in Nature Protocols (2007)

  2. No Access

    Article

    Controversial BRCA1 allelotypes in commonly used breast cancer cell lines

    Sivasundaram Karnan, Morassa Mohseni, Yuko Konishi in Breast Cancer Research and Treatment (2010)

  3. Article

    Open Access

    Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old

    Hepatocellular carcinoma (HCC) is the third-leading cause of cancer-related deaths worldwide. It is often diagnosed at an advanced stage, and hence typically has a poor prognosis. To identify distinct molecula...

    Dilek Colak, Muhammad A Chishti, Al-Bandary Al-Bakheet in Molecular Cancer (2010)

  4. Article

    Open Access

    The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

    Although a high frequency of androgen receptor (AR) expression in human breast cancers has been described, exploiting this knowledge for therapy has been challenging. This is in part because androgens can eith...

    Joseph P Garay, Bedri Karakas, Abde M Abukhdeir, David P Cosgrove in Breast Cancer Research (2012)

  5. No Access

    Chapter

    Circulating Cell-Free DNA for Molecular Diagnostics and Therapeutic Monitoring

    The presence of cell-free circulating DNA has been known for many years, but only recently has this knowledge been translated for diagnosis and therapeutic monitoring. In part this is due to the fact that tech...

    Julia A. Beaver, Ben H. Park in Genomic Applications in Pathology (2015)

  6. No Access

    Article

    Male breast cancer: a disease distinct from female breast cancer

    Male breast cancer (BC) is rare, representing approximately 1% of cancers that occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not much is known about the disease, and treatmen...

    Ayca Gucalp, Tiffany A. Traina, Joel R. Eisner in Breast Cancer Research and Treatment (2019)

  7. Article

    The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer

    Advances in genomic strategies and the development of targeted therapies have enabled precision medicine to revolutionise the field of oncology. Precision medicine uses patient-specific genetic and molecular i...

    Brad A. Davidson, Sarah Croessmann, Ben H. Park in British Journal of Cancer (2021)

  8. Article

    Open Access

    Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

    Cribriform prostate cancer, found in both invasive cribriform carcinoma (ICC) and intraductal carcinoma (IDC), is an aggressive histological subtype that is associated with progression to lethal disease. To de...

    Hong Yuen Wong, Quanhu Sheng, Amanda B. Hesterberg in Nature Communications (2022)

  9. Article

    Open Access

    Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

    The AURORA US Metastasis Project was established with the goal to identify molecular features associated with metastasis. We assayed 55 females with metastatic breast cancer (51 primary cancers and 102 metasta...

    Susana Garcia-Recio, Toshinori Hinoue, Gregory L. Wheeler in Nature Cancer (2023)

  10. Article

    Open Access

    Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

    Recent advancements in high-throughput genomics and targeted therapies have provided tremendous potential to identify and therapeutically target distinct mutations associated with cancers. However, to date the...

    Adam X. Miranda, Justin Kemp, Brad A. Davidson, Sara Erika Bellomo in BMC Genomics (2024)